Press Release: Prime Therapeutics : Prime Therapeutics highlights industry-leading GLP-1 research at AMCP 2025
/PRNewswire/ -- As the indications and demand for glucagon-like peptide-1 (GLP-1) agonist drugs continue to expand, the real-world GLP-1 research and...
Read full article »
Prime Therapeutics is a Minnesota-based company that provides pharmacy benefit management services for health plans, employers and government programs.
Read more